HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immunogenicity and reactogenicity of DTPa-IPV/Hib vaccine co-administered with hepatitis B vaccine for primary and booster vaccination of Taiwanese infants.

Abstract
Immunogenicity and reactogenicity of the combined diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b (Hib) conjugate vaccine (DTPa-IPV/Hib, Infanrix™-IPV + Hib) was assessed when co-administered with hepatitis B (HBV) vaccine. Seventy healthy infants received DTPa-IPV/Hib at 1.5, 3.5, 6 and 15-18 months, and HBV at birth, 1.5, 6 and 15-18 months of age. Serological responses were assessed. Diphtheria, tetanus, Hib and pertussis seroprotection/seropositivity rates were 100% after primary vaccination. Post-primary immune responses to poliovirus could not be evaluated for technical reasons. However, after the booster dose, seroprotection/seropositivity rates, including poliovirus, were 100%. Over 95% were seroprotected against HBV. Post-booster geometric mean antibody concentrations/titers (GMC/GMTs) rose from 14-fold to 45-fold, indicating effective priming against all antigens, including polioviruses. DTPa-IPV/Hib was well tolerated alone or co-administered with HBV. No serious adverse events were considered related to vaccination. Primary and booster vaccination with combined DTPa-IPV/Hib and HBV was immunogenic and well tolerated. Combination vaccines enable vaccine providers to conveniently provide routine pediatric immunizations, with minimal discomfort.
AuthorsPei-Lan Shao, Chun-Yi Lu, Yu-Chia Hsieh, Hans L Bock, Li-Min Huang, Taiwan Infanrix-069 Study Group
JournalJournal of the Formosan Medical Association = Taiwan yi zhi (J Formos Med Assoc) Vol. 110 Issue 6 Pg. 415-22 (Jun 2011) ISSN: 0929-6646 [Print] Singapore
PMID21741011 (Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2011 Formosan Medical Association & Elsevier. Published by Elsevier B.V. All rights reserved.
Chemical References
  • DTPa-HBV-IPV combined vaccine
  • Diphtheria-Tetanus-Pertussis Vaccine
  • Haemophilus Vaccines
  • Hepatitis B Vaccines
  • Poliovirus Vaccine, Inactivated
  • Vaccines, Combined
  • Vaccines, Conjugate
Topics
  • Antibody Formation (immunology)
  • Diphtheria-Tetanus-Pertussis Vaccine (administration & dosage, adverse effects, immunology)
  • Haemophilus Vaccines (administration & dosage, adverse effects, immunology)
  • Hepatitis B Vaccines (administration & dosage, adverse effects, immunology)
  • Humans
  • Immunization Schedule
  • Immunization, Secondary (standards)
  • Infant
  • Monitoring, Immunologic (methods)
  • Poliovirus Vaccine, Inactivated (administration & dosage, adverse effects, immunology)
  • Vaccines, Combined (administration & dosage, adverse effects, immunology)
  • Vaccines, Conjugate (administration & dosage, adverse effects, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: